Mesenchymal Cell Reprogramming in Experimental MPL^W515L Mouse Model of Myelofibrosis

• Ying Han ,

  Contributed equally to this work with: Ying Han, Lanzhu Yue

  Affiliations Department of Immunology, Moffitt Cancer Center, Tampa, Florida, United States of America, Department of Biotherapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Immunology and Biotherapy, Key Laboratory of Cancer Prevention and Therapy, Tianjin, PR China

  ⨯
• Lanzhu Yue ,

  Contributed equally to this work with: Ying Han, Lanzhu Yue

  Affiliations Department of Immunology, Moffitt Cancer Center, Tampa, Florida, United States of America, Department of Hematology, Tianjin medical University General Hospital, Tianjin, PR China

  ⨯
• Max Wei,

  Affiliation Department of Immunology, Moffitt Cancer Center, Tampa, Florida, United States of America

  ⨯
• Xiubao Ren,

  Affiliation Department of Biotherapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Immunology and Biotherapy, Key Laboratory of Cancer Prevention and Therapy, Tianjin, PR China

  ⨯
• Zonghong Shao,

  Affiliation Department of Hematology, Tianjin medical University General Hospital, Tianjin, PR China

  ⨯
• Ling Zhang,

  Affiliation Department of Hematopathology, Moffitt Cancer Center, Tampa, Florida, United States of America

  ⨯
• Ross L. Levine,

  Affiliation Leukemia Center, Memorial Sloan Kettering Cancer Center, New York City, New York, United States of America

  ⨯
• Pearlie K. Epling-Burnette

  * E-mail: Pearlie.Burnette@moffitt.org

  Affiliation Department of Immunology, Moffitt Cancer Center, Tampa, Florida, United States of America

  ⨯